Figure 3.

Association of APOA5 −1131T>C genotypes and equivalent differences in circulating triglyceride concentration with risk of coronary heart disease

Non-lipid factors adjusted for included smoking status, systolic blood pressure, body-mass index, and history of diabetes (webappendix p 5). Size of data markers is proportional to the inverse of the variance of the weighted mean difference (the reference group is represented by a square with an arbitrary fixed size) and the vertical lines represent 95% CIs. *Reference group. †Odds ratio for coronary heart disease associated with APOA5 −1131T>C. ‡Hazard ratio for coronary heart disease in prospective studies for differences in usual triglyceride concentration equal to those recorded with APOA5 −1131T>C (as reported in figure 1).